Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.

Highest usefulness score first. Studies without a score come last.

  1. New treatment modalities in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. World journal of clinical cases 2019-07-26 Drug development

    Alzheimer's disease (AD) is still a major public health challenge without an effective treatment to prevent or stop it.

  2. Glucagon-Like Peptide-1 Cleavage Product Improves Cognitive Function in a Mouse Model of Down Syndrome

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. eNeuro 2019-05-15 Drug development

    Currently there is no effective therapy available for cognitive impairments in Down syndrome (DS), one of the most prevalent forms of intellectual disability in humans associated with the chromosomes 21 trisomy.

  3. Pancreatic islet (of Langerhans) revisited

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Histology and histopathology 2019-04-25 Drug development

    One hundred and fifty years ago, Paul Langerhans described what would come to be known as pancreatic 'islet of Langerhans'.

  4. The role of gut microbiota in pathogenesis of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Journal of applied microbiology 2019-04-15 Disease mechanisms

    This paper describes the effects of the gut microbiota on the pathogenesis of Alzheimer's pathology by evaluating the current original key findings and identifying gaps in the knowledge required for validation.

  5. Expression of GLP-1 receptors in insulin-containing interneurons of rat cerebral cortex

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Diabetologia 2019-01-12 Drug development

    Single-cell digital PCR revealed GLP-1 receptor expression in neurogliaform cells and showed that copy numbers of mRNA of the Glp1r gene in hyperglycaemia exceeded those in hypoglycaemia by 9.6 times (p < 0.008).

  6. Liraglutide Ameliorates Hyperhomocysteinemia-Induced Alzheimer-Like Pathology and Memory Deficits in Rats via Multi-molecular Targeting

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Neuroscience bulletin 2019-01-10 Drug development

    Hyperhomocysteinemia (Hhcy) is an independent risk factor for Alzheimer's disease (AD), and insulin-resistance is commonly seen in patients with Hhcy.

  7. Exercise and retinal health

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Restorative neurology and neuroscience 2019 Brain scans and imaging

    Many ocular diseases (such as glaucoma, diabetic retinopathy, age-related macular degeneration, and traumatic eye injuries) can result in the degeneration of retinal cells and the subsequent loss of vision.

  8. Protective Effects of Incretin Against Age-Related Diseases

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Current drug delivery 2019 Drug development

    Incretin contains two peptides named glucagon-like peptide-1(GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).

  9. Therapeutic Strategies for Alzheimer's Disease in the View of Diabetes Mellitus

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Advances in experimental medicine and biology 2019 Drug development

    Recently, Alzheimer's disease (AD) is understood as "diabetes of the brain" or "type 3 diabetes."

  10. Therapeutic Approaches to Alzheimer's Type of Dementia: A Focus on FGF21 Mediated Neuroprotection

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Current pharmaceutical design 2019 Risk factors

    Neurodegenerative disorders are the most devastating disorder of the nervous system.

  11. The intestinal microbiome and its relevance for functionality in older persons

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Current opinion in clinical nutrition and metabolic care 2019-01 Disease mechanisms

    Some observational studies have instead demonstrated that, in older individuals, frailty and Alzheimer-type dementia are associated with fecal microbiota dysbiosis, that is, reduced biodiversity and overexpression of pathobionts.

  12. Blood Flow Deficits and Cerebrovascular Changes in a Dietary Model of Hyperhomocysteinemia

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. ASN neuro 2019 Vascular contributions

    Elevated homocysteine in the blood, or hyperhomocysteinemia, is a recognized risk factor for multiple causes of dementia including Alzheimer’s disease.

  13. Noradrenergic Regulation of Hippocampus-Dependent Memory

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Central nervous system agents in medicinal chemistry 2019 Disease mechanisms

    Neuromodulation regulates critical functions of CNS synapses, ranging from neural circuit development to high-order cognitive processes, including learning and memory.

  14. Interplay between Nutrition and Hearing Loss: State of Art

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Nutrients 2018-12-24 Risk factors

    Hearing loss has been recently ranked as the fifth leading cause of years lived with disability, ahead of many other chronic diseases such as diabetes, dementia, or chronic obstructive pulmonary disease.

  15. The intestinal microbiome and Alzheimer's disease: A review

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Animal models and experimental medicine 2018-09-25 Disease mechanisms

    Alzheimer's disease (AD) is an increasingly common neurodegenerative disease.

  16. Thiamine deficiency contributes to synapse and neural circuit defects

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Biological research 2018-09-19 Disease mechanisms

    To demonstrate this hypothesis, we established abnormalities in the glucose metabolism utilizing thiamine deficiency in vitro and in vivo, and we found dramatically reduced dendrite spine density.

  17. Rapid and in situ optical detection of trace lithium in tissues

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Biomedical optics express 2018-08-27 Drug development

    Lithium-based medications are used successfully to treat many mental disorders, including bipolar disorder and Alzheimer's disease.

  18. Too sweet: Problems of protein glycation in the eye

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Experimental eye research 2018-08-24 Brain scans and imaging

    Laboratory and epidemiological data indicate that high blood sugar levels and/or consuming high glycemia diets are linked to multiple age-related diseases, including age-related macular degeneration, cataract, Parkinson's disease, Alzheimer's disease, diabetic retinopathy, and, apparently glaucoma.

  19. The Molecular Intersection Between Senescence and Major Depression in the Elderly

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2018-07-24 Risk factors

    Major depressive disorder in the elderly-or late-life depression (LLD)-is one of the most common mental illnesses in the aging population.

  20. Liraglutide for psychiatric disorders: clinical evidence and challenges

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Hormone molecular biology and clinical investigation 2018-07-18 Drug development

    Obesity and diabetes are both risk factors and consequences of psychiatric disorders.

  21. Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Oxidative medicine and cellular longevity 2018-07-09 Disease mechanisms

    Insulin resistance (IR), a key component of the metabolic syndrome, precedes the development of diabetes, cardiovascular disease, and Alzheimer's disease.

  22. Strong Circadian Rhythms in the Choroid Plexus: Implications for Sleep-Independent Brain Metabolite Clearance

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Journal of experimental neuroscience 2018-07-05 Risk factors

    Cerebrospinal fluid (CSF) is a fluidic part of the brain's microenvironment that isolates the brain from the rest of the body.

  23. iPSC-derived familial Alzheimer's PSEN2 N141I cholinergic neurons exhibit mutation-dependent molecular pathology corrected by insulin signaling

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Molecular neurodegeneration 2018-06-26 Risk genes beyond APOE

    We report herein that wildtype, PSEN2 N141I and CRISPR/Cas9-corrected iPSC-derived BFCNs (and their precursors) show indistinguishable insulin signaling profiles as determined by the phosphorylation of canonical insulin signaling pathway molecules.

  24. Frailty and the gut

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2018-03-16 Disease mechanisms

    Frailty, which is a syndrome that encompasses losses in physical, psychological and social domains, is responsible for enhanced vulnerability to endogenous and/or exogenous stressors.

  25. Neuroinflammation, Gut Microbiome, and Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Molecular neurobiology 2018-03-09 Costs and economics

    Alzheimer's disease (AD) is a progressive neurodegenerative disease that develops insidiously and causes dementia finally.

From across this topic

10 of the 1,048 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.

Other topics